Tag Archives: APRI

Hot High Tech Stocks To Own For 2019

Equities analysts predict that AnaptysBio Inc (NASDAQ:ANAB) will report ($0.69) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for AnaptysBio’s earnings. The lowest EPS estimate is ($0.72) and the highest is ($0.66). AnaptysBio posted earnings of ($0.45) per share during the same quarter last year, which indicates a negative year-over-year growth rate of 53.3%. The firm is expected to report its next earnings report on Tuesday, November 6th.

Zacks Investment Research’s earnings per share calculations are an average based on a survey of analysts that that provide coverage for AnaptysBio.

Get AnaptysBio alerts:

AnaptysBio (NASDAQ:ANAB) last posted its quarterly earnings results on Tuesday, August 7th. The biotechnology company reported ($0.57) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.70) by $0.13.

Hot High Tech Stocks To Own For 2019: Western Copper and Gold Corporation(WRN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Western Copper (NYSEAMERICAN:WRN) (TSE:WRN) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 367,976 shares, an increase of 17.9% from the May 31st total of 312,021 shares. Based on an average daily trading volume, of 131,386 shares, the short-interest ratio is currently 2.8 days.

Hot High Tech Stocks To Own For 2019: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Eaton Vance Management bought a new position in shares of iShares PHLX Semiconductor ETF (NASDAQ:SOXX) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,125 shares of the exchange traded fund’s stock, valued at approximately $203,000.

  • [By Nicholas Rossolillo]

    Part of the reasoning behind Morgan Stanley’s cautious outlook on semiconductors is the stellar run chip stocks have had since 2016. The sector — as measured by the iShares PHLX Semiconductor ETF (NASDAQ:SOXX) — has handily beaten the broader stock market.

  • [By Jim Crumly]

    Semiconductor stocks rose on news of a deal with China to grant a reprieve to ZTE, with the iShares PHLX Semiconductor ETF (NASDAQ:SOXX) moving up 1.2%. Energy shares gained, too; the SPDR S&P Oil & Gas Exploration & Production ETF (NYSEMKT:XOP) closed up 1.3%.

  • [By Jim Crumly]

    Technology was the weakest sector, with biotech and semiconductor stocks in particular having a tough day. The SPDR S&P Biotech ETF (NYSEMKT:XBI) tumbled 3.2% and the iShares PHLX Semiconductor ETF (NASDAQ:SOXX) lost 2.4%.

  • [By Ethan Ryder]

    Madrona Financial Services LLC increased its stake in shares of iShares PHLX Semiconductor ETF (NASDAQ:SOXX) by 14.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,356 shares of the exchange traded fund’s stock after buying an additional 1,025 shares during the quarter. iShares PHLX Semiconductor ETF comprises approximately 1.2% of Madrona Financial Services LLC’s holdings, making the stock its 17th largest position. Madrona Financial Services LLC’s holdings in iShares PHLX Semiconductor ETF were worth $1,489,000 at the end of the most recent reporting period.

Hot High Tech Stocks To Own For 2019: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA’s review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

Hot High Tech Stocks To Own For 2019: Gentex Corporation(GNTX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Delphi Technologies (NYSE: DLPH) and Gentex (NASDAQ:GNTX) are both mid-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

  • [By Max Byerly]

    Gentex Co. (NASDAQ:GNTX) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $25.38 and last traded at $25.31, with a volume of 61480 shares trading hands. The stock had previously closed at $25.10.

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Gentex (NASDAQ:GNTX) from a buy rating to a hold rating in a research report released on Saturday morning.

    GNTX has been the topic of several other reports. Susquehanna Bancshares set a $25.00 price target on shares of Gentex and gave the stock a hold rating in a research note on Sunday, April 22nd. ValuEngine downgraded shares of Gentex from a buy rating to a hold rating in a research note on Wednesday, May 2nd. Zacks Investment Research raised shares of Gentex from a hold rating to a buy rating and set a $25.00 price target on the stock in a research note on Monday, April 23rd. Longbow Research reissued a buy rating and issued a $28.00 price target on shares of Gentex in a research note on Monday, April 23rd. Finally, JPMorgan Chase & Co. decreased their price target on shares of Gentex from $26.00 to $25.00 and set a neutral rating on the stock in a research note on Tuesday, April 24th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus target price of $25.60.

Hot High Tech Stocks To Own For 2019: GTT Communications, Inc.(GTT)

Advisors’ Opinion:

  • [By ]

    GTT Communications (GTT) : “I think they have a great business model. I say buy, buy, buy.”

    Steel Dynamics (STLD) : “That’s a great steel company and the only one I’ll recommend other than Nucor (NUE) .”

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on GTT Communications (GTT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

    Get GTT Communications alerts:

    GTT to Present at Spring 2018 Investor Conferences (finance.yahoo.com) Unified Communications Week in Review: Firstcom, 8×8, RingCentral (unified-communications.tmcnet.com) RingCentral, SD-WAN vendors team up to deliver UCaaS (searchunifiedcommunications.techtarget.com) GTT Communications (GTT) CEO Richard Calder Sells 6,000 Shares (americanbankingnews.com) GTT Communications (GTT) EVP Chris Mckee Sells 7,000 Shares (americanbankingnews.com)

    GTT has been the topic of several recent research reports. Oppenheimer increased their price objective on GTT Communications from $52.00 to $68.00 in a research report on Tuesday, February 27th. William Blair reiterated a “buy” rating on shares of GTT Communications in a research report on Wednesday, March 28th. Craig Hallum reiterated a “buy” rating and set a $60.00 price objective (up from $50.00) on shares of GTT Communications in a research report on Monday, February 26th. SunTrust Banks increased their price objective on GTT Communications to $60.00 and gave the company a “buy” rating in a research report on Friday, March 2nd. Finally, Jefferies Group increased their price objective on GTT Communications to $62.00 and gave the company a “buy” rating in a research report on Friday, March 2nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $57.22.

  • [By Max Byerly]

    GTT Communications (NYSE:GTT)‘s stock had its “overweight” rating reissued by equities research analysts at KeyCorp in a report issued on Friday, The Fly reports. They presently have a $45.00 target price on the technology company’s stock. KeyCorp’s target price would suggest a potential upside of 43.95% from the stock’s current price.

  • [By Lisa Levin]

    Analysts at KeyBanc upgraded GTT Communications, Inc. (NYSE: GTT) from Sector Weight to Overweight.

    GTT Communications shares fell 0.64 percent to $46.35 in pre-market trading.

Hot High Tech Stocks To Own For 2019: National Grid Transco, PLC(NGG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    MML Investors Services LLC lessened its holdings in National Grid plc (NYSE:NGG) by 8.7% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 34,440 shares of the utilities provider’s stock after selling 3,290 shares during the quarter. MML Investors Services LLC’s holdings in National Grid were worth $1,943,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Tyler Crowe]

    National Grid (NYSE:NGG) has been about as solid of a dividend investment as any investor could ask for over the past decade. The company is the epitome of utility stocks as its regulated electricity and natural gas transmission businesses bear almost no commodity price or power-generation risk. For investors, the trade-off for that stability has been a rather slow rate of growth. 

  • [By Anders Bylund, Timothy Green, and Brian Feroldi]

    So we asked a few Motley Fool contributors to share some alternatives to GM’s attractive dividend yields. Read on to see why our panelists recommended Pitney Bowes (NYSE:PBI), National Grid (NYSE:NGG), and AT&T (NYSE:T).

Top Blue Chip Stocks To Invest In 2019

Wall Street veteran Sam Stovall is warning stock investors the longest bull market on record will end with an epic meltdown.

According to the CFRA chief investment strategist, it’s a side effect of an unprecedented business cycle.

“Three conditions: Very long, very high, very expensive,” Stovall said Tuesday on CNBC’s “Futures Now.” “History would imply that be careful because now we’re likely to fall into a very deep bear market when it does finally hit with the average decline being close to 40 percent plus.”

His latest thoughts came as the Dow was hitting record highs. The blue chip index is now up more than 8 percent this year. The S&P 500 is performing a tad better — up more than 9 percent for 2018.

Since the bull market began on March 9, 2009, the Dow and S&P 500 have soared more than 300 percent each. For now, Stovall doesn’t see any near-term signs that the win streak is about to end.

Top Blue Chip Stocks To Invest In 2019: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA’s review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

Top Blue Chip Stocks To Invest In 2019: ENERGY TRANSFER PARTNERS(ETP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Metaverse ETP (CURRENCY:ETP) traded down 6.4% against the U.S. dollar during the twenty-four hour period ending at 21:00 PM E.T. on May 27th. Metaverse ETP has a total market cap of $30.72 million and $4.17 million worth of Metaverse ETP was traded on exchanges in the last 24 hours. During the last week, Metaverse ETP has traded down 6.4% against the U.S. dollar. One Metaverse ETP coin can now be purchased for about $0.86 or 0.00011713 BTC on popular exchanges including TDAX, HitBTC, TOPBTC and Bitfinex.

  • [By Matthew DiLallo]

    After lots of analysis and discussion, Energy Transfer Equity recently announced that it has agreed to merge with its MLP Energy Transfer Partners (NYSE:ETP) in a $27 billion deal that will create a nearly $100 billion energy infrastructure behemoth. In addition to increasing the size and scale of the company, several other reasons were highlighted by CFO Tom Long about why the company is happy to finally be able to announce this transaction: 

  • [By Matthew DiLallo]

    When a dividend yield gets over 10%, it’s usually a sign that the market believes a cut is coming down the pipeline. Given that Energy Transfer Partners (NYSE:ETP) and Summit Midstream Partners (NYSE:SMLP) currently yield 11.6% and 14.5%, respectively, the market seems to believe that will be the case for both of those master limited partnerships. That’s why investors should steer clear of those two high-yielding stocks and instead consider Crestwood Equity Partners’ (NYSE:CEQP) much safer 7% payout.

Top Blue Chip Stocks To Invest In 2019: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By George Budwell]

    The small-cap immuno-oncology company Agenus (NASDAQ:AGEN) and the inhaled insulin company MannKind Corporation (NASDAQ:MNKD) are prime examples of this phenomenon. Even though both of these companies have been in existence for over two decades, these two particular biotechs have failed to bring a product to market capable of generating a significant revenue stream. As a result, these two companies have essentially been forced to wipe out their early shareholders through serial dilution.

  • [By George Budwell]

    Agenus (NASDAQ:AGEN), a small-cap cancer immunotherapy and vaccine company, has started to claw its way back from a steep downturn that began last April. Specifically, the drugmaker’s shares have spiked by a healthy 29% over just the past three trading sessions. 

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

Top 10 High Tech Stocks To Buy For 2019

COB and CEO of Facebook Inc (NASDAQ:FB) Mark Zuckerberg sold 248,984 shares of FB on 08/15/2017 at an average price of $170.69 a share. The total sale was $42.5 million.

Facebook Inc is the world’s largest online social network. Its products are Facebook, Instagram, Messenger, WhatsApp, and Oculus. Its products enable people to connect and share through mobile devices and personal computers. Facebook Inc has a market cap of $493.71 billion; its shares were traded at around $170.00 with a P/E ratio of 36.78 and P/S ratio of 15.12. Facebook Inc had annual average EBITDA growth of 40.60% over the past five years.

CEO Recent Trades:

COB and CEO, 10% Owner Mark Zuckerberg sold 248,984 shares of FB stock on 08/15/2017 at the average price of $170.69. The price of the stock has decreased by 0.4% since.

Directors and Officers Recent Trades:

VP Marketing & Bus. Part. David B. Fischer sold 50,533 shares of FB stock on 08/10/2017 at the average price of $169.95. The price of the stock has increased by 0.03% since.VP and General Counsel Colin Stretch sold 750 shares of FB stock on 08/08/2017 at the average price of $171.88. The price of the stock has decreased by 1.09% since.Chief Technology Officer Michael Todd Schroepfer sold 37,963 shares of FB stock on 08/08/2017 at the average price of $171.98. The price of the stock has decreased by 1.15% since.Chief Product Officer Christopher K Cox sold 16,000 shares of FB stock on 08/07/2017 at the average price of $169.95. The price of the stock has increased by 0.03% since.VP and General Counsel Colin Stretch sold 750 shares of FB stock on 08/01/2017 at the average price of $169.93. The price of the stock has increased by 0.04% since.

For the complete insider trading history of FB, click here

Top 10 High Tech Stocks To Buy For 2019: Oriental Financial Group Inc.(OFG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Engineers Gate Manager LP increased its stake in shares of OFG Bancorp (NYSE:OFG) by 62.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 76,455 shares of the bank’s stock after buying an additional 29,451 shares during the period. Engineers Gate Manager LP’s holdings in OFG Bancorp were worth $799,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Bank of Marin Bancorp (NASDAQ: BMRC) and OFG Bancorp (NYSE:OFG) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings.

  • [By Joseph Griffin]

    Stevens Capital Management LP purchased a new stake in shares of OFG Bancorp (NYSE:OFG) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 16,250 shares of the bank’s stock, valued at approximately $170,000.

  • [By Ethan Ryder]

    OFG Bancorp (NYSE:OFG) will release its earnings data before the market opens on Friday, July 20th. Analysts expect OFG Bancorp to post earnings of $0.23 per share for the quarter.

  • [By Max Byerly]

    Shares of OFG Bancorp (NYSE:OFG) dropped 6.3% during trading on Monday . The company traded as low as $16.45 and last traded at $16.50. Approximately 794,358 shares changed hands during mid-day trading, an increase of 153% from the average daily volume of 313,807 shares. The stock had previously closed at $17.60.

  • [By Lisa Levin]

    Friday afternoon, the financial shares climbed 0.11 percent. Meanwhile, top gainers in the sector included Farmers Capital Bank Corporation (NASDAQ: FFKT), up 16 percent, and OFG Bancorp (NYSE: OFG), up 10 percent.

Top 10 High Tech Stocks To Buy For 2019: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Max Byerly]

    Proteon Therapeutics (NASDAQ: PRTO) and Neurocrine Biosciences (NASDAQ:NBIX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Top 10 High Tech Stocks To Buy For 2019: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By Keith Speights]

    Dividend Yield

    Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88%
    AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97%
    Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29%
    DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A
    Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77%
    Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A
    Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57%
    Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A
    MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A
    Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14%
    Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22%
    Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61%
    Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82%
    Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A
    Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64%
    Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A
    Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

    Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.

  • [By Jon C. Ogg]

    Eli Lilly and Co. (NYSE: LLY) also has a Neutral rating, and it was trading at $105.00. Merrill Lynch raised its price objective to $106 from $101, and the consensus analyst target price is $97.13.

  • [By Chris Lange]

    Eli Lilly and Co.’s (NYSE: LLY) short interest decreased to 12.64 million shares from the previous 14.20 million. The stock was trading at $106.21. The 52-week range is $73.69 to $107.84.

  • [By Chris Lange]

    Eli Lilly and Co. (NYSE: LLY) is set to report its most recent results Tuesday morning as well. The analysts’ consensus estimates are $1.14 in EPS on revenue of $5.49 billion. Shares were changing hands at $79.06 on Friday’s close. The consensus price target is $90.80, and the 52-week range is $73.69 to $89.09.

  • [By Ethan Ryder]

    Eli Lilly And Co (NYSE:LLY) major shareholder Lilly Endowment Inc sold 92,447 shares of the company’s stock in a transaction that occurred on Thursday, September 27th. The shares were sold at an average price of $107.00, for a total value of $9,891,829.00. Following the completion of the sale, the insider now owns 119,508,357 shares in the company, valued at approximately $12,787,394,199. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

  • [By Motley Fool Staff]

    Eli Lilly & Co. (NYSE:LLY) is a Goliath in diabetes treatment, and thanks to new drugs that can help patients control their disease better, the company’s diabetes sales are soaring.

Top 10 High Tech Stocks To Buy For 2019: Bellerophon Therapeutics, Inc.(BLPH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Radius Health (NASDAQ:RDUS) and Bellerophon Therapeutics (NASDAQ:BLPH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership.

  • [By Money Morning Staff Reports]

    However, it’s unlikely Netlist repeats these returns anytime soon. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 230%…

    Penny Stock Current Share Price Last Week’s Gain
    Netlist Inc. (Nasdaq: NLST) $0.83 542.67%
    Mannkind Corp. (Nasdaq: MNKD) $1.80 79.09%
    Fred’s Inc. (Nasdaq: FRED) $2.49 73.68%
    Delcath Systems Inc. (OTCMKTS: DCTH) $3.70 72.63%
    Gemphire Therapeutics Inc. (Nasdaq: GEMP) $1.96 50.71%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $1.05 47.98%
    Cel-Sci Corp. (NYSE: CVM) $3.78 44.78%
    ParkerVision Inc. (OTCMKTS: PRKR) $0.60 29.42%
    Superior Drilling Products Inc. (NYSE: SDPI) $2.63 29.23%
    LiqTech International Inc. (NYSE: LIQT) $1.50 25.20%

    How to Profit off This $11.1 Billion Money Pool: By following a few simple steps, one IRS directive could help set you up to receive checks of up to $1,795 every single month thanks to a genius investment. Learn more…

  • [By Stephan Byrd]

    Press coverage about Bellerophon Therapeutics (NASDAQ:BLPH) has trended somewhat positive on Thursday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bellerophon Therapeutics earned a news impact score of 0.14 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 46.948363531679 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 High Tech Stocks To Buy For 2019: Tejon Ranch Co(TRC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Terracoin (CURRENCY:TRC) traded down 14.6% against the dollar during the 24 hour period ending at 23:00 PM ET on May 17th. In the last week, Terracoin has traded 20.7% higher against the dollar. Terracoin has a market cap of $4.06 million and $4,377.00 worth of Terracoin was traded on exchanges in the last 24 hours. One Terracoin coin can now be bought for about $0.18 or 0.00002218 BTC on popular exchanges including CoinExchange, Trade Satoshi, C-CEX and Cryptopia.

  • [By Ethan Ryder]

    Terracoin (CURRENCY:TRC) traded up 10% against the dollar during the twenty-four hour period ending at 11:00 AM E.T. on October 8th. Terracoin has a total market cap of $2.09 million and approximately $4,720.00 worth of Terracoin was traded on exchanges in the last day. In the last seven days, Terracoin has traded down 15.3% against the dollar. One Terracoin coin can currently be bought for approximately $0.0910 or 0.00001375 BTC on popular exchanges including Trade Satoshi, CoinExchange, Cryptopia and C-CEX.

Top 10 High Tech Stocks To Buy For 2019: Orchids Paper Products Company(TIS)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    After looking at last week’s top-performing penny stocks, we’ll show you a penny stock on the verge of jumping over 159%…

    Penny Stock Current Share Price Last Week’s Gain
    My Size Inc. (NASDAQ: MYSZ) $1.19 60.71%
    Delcath Systems Inc. (OTCMKTS: DCTH) $3.21 52.38%
    Regional Health Properties Inc. (NYSE: RHE) $0.18 49.39%
    Nemaura Medical Inc. (NASDAQ: NMRD) $3.03 44.89%
    3Pea International Inc. (NASDAQ: TPNL) $4.62 42.24%
    PLx Pharma Inc. (NASDAQ: PLXP) $4.22 34.38%
    Orchids Paper Products Co. (NYSE: TIS) $3.99 34.30%
    DelMar Pharmaceuticals Inc. (NASDAQ: DMPI) $0.74 33.41%
    Restoration Robotics Inc. (NASDAQ: HAIR) $3.08 32.74%
    Renren Inc. (NYSE: RENN) $1.69 32.61%

    Don’t Miss Out: The Treasury is sitting on an $11.1 billion cash pile, and a loophole entitles Americans to a sizable portion. Some are collecting $1,795, $3,000, or $5,000 every month thanks to this powerful investment…

  • [By Paul Ausick]

    Orchids Paper Products Co. (NYSEAMERICAN: TIS) dropped more than 12% Monday to set a new 52-week low of $0.70. Shares closed at $0.80 on Friday and the stock’s 52-week high is $15.47. Volume totaled around 15 million, about 60 times the daily average of around 250,000. The company had no specific news. Shares have made a massive comeback and are on track to close at $2.47, up more than 200%.

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Lisa Levin] Gainers
    SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
    EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
    Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
    Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose
  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares jumped 104.82 percent to close at $14.87 on Tuesday.
    EVINE Live Inc. (NASDAQ: EVLV) rose 31.25 percent to close at $1.06. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    SemiLEDs Corporation (NASDAQ: LEDS) shares climbed 27.16 percent to close at $4.26 on Tuesday.
    Atossa Genetics Inc. (NASDAQ: ATOS) gained 27.09 percent to close at $3.80. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) surged 17.13 percent to close at $37.95 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares gained 15.91 percent to close at $18.21 following upbeat quarterly earnings.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 15.73 percent to close at $7.58 on Tuesday after declining 1.50 percent on Monday.
    Sanmina Corp (NASDAQ: SANM) shares gained 14.62 percent to close at $31.75 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Orchids Paper Products Company (NYSE: TIS) jumped 12.86 percent to close at $7.37. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 12.8 percent to close at $7.05 following strong quarterly results.
    Avid Bioservices, Inc. (NASDAQ: CDMO) rose 12.72 percent to close at $3.81.
    Genprex, Inc. (NASDAQ: GNPX) gained 12.61 percent to close at $5.00.
    Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose 12.39 percent to close at $3.72.
    NextDecade Corporation (NASDAQ: NEXT) shares climbed 11.88 percent to close at $7
  • [By Money Morning Staff Reports]

    Last week’s top performing penny stock, Orchids Paper Products Co. (NYSE: TIS), jumped over 218% after the company delivered a stellar earnings reports on Aug. 13.

Top 10 High Tech Stocks To Buy For 2019: Intercontinental Exchange Inc.(ICE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Canlan Ice Sports Corp (TSE:ICE) declared a quarterly dividend on Friday, August 10th, Zacks reports. Stockholders of record on Friday, September 28th will be paid a dividend of 0.025 per share on Tuesday, October 16th. This represents a $0.10 annualized dividend and a dividend yield of 2.01%. The ex-dividend date of this dividend is Thursday, September 27th. This is an increase from Canlan Ice Sports’s previous quarterly dividend of $0.02.

  • [By Joseph Griffin]

    Shares of Intercontinental Exchange (NYSE:ICE) have earned an average recommendation of “Buy” from the sixteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $78.36.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Intercontinental Exchange (ICE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    OTC Markets Group (OTCMKTS:OTCM) and Intercontinental Exchange (NYSE:ICE) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.

Top 10 High Tech Stocks To Buy For 2019: Cullen/Frost Bankers, Inc.(CFR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jordan Wathen, Matthew Frankel, CFP, and Dan Caplinger]

    Below, three Motley Fool contributors lay the case for Cullen/Frost Bankers (NYSE:CFR), Morgan Stanley (NYSE:MS), and Synchrony Financial (NYSE:SYF) as ways to profit from a rising tide for bank stocks.

  • [By Anders Bylund, Jason Hall, Danny Vena, Jordan Wathen, and Brian Feroldi]

    In that spirit, we asked a few of our Motley Fool investors what they see as the best investment ideas at the start of July, 2018. They were quick to suggest Chinese e-commerce giant Baidu (NASDAQ:BIDU), coffee giant Starbucks (NASDAQ:SBUX), clean energy specialist TerraForm Power (NASDAQ:TERP), semiconductor veteran Intel, (NASDAQ:INTC), and Texan bank Cullen/Frost Bankers (NYSE:CFR).

  • [By Brian Feroldi]

    Cullen/Frost Bankers (NYSE:CFR), a regional bank based in Texas, reported its second-quarter results on Thursday, July 26. A favorable lending environment combined with rising interest rates to drive earnings-per-share growth of 30%.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    News articles about Cullen/Frost Bankers (NYSE:CFR) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cullen/Frost Bankers earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned news stories about the bank an impact score of 46.1866283388257 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 10 High Tech Stocks To Buy For 2019: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Guidewire Software (NYSE:GWRE) is scheduled to be announcing its earnings results after the market closes on Wednesday, September 5th. Analysts expect the company to announce earnings of $0.54 per share for the quarter.

  • [By Garrett Baldwin]

    Starbuck’s Corp. (Nasdaq: SBUX) Executive Chair Howard Schultz announced he will depart the company. Many are speculating he will pursue a career in politics and potentially seek the Democratic nomination for president in 2020. Schultz had previously denied any speculation around a role in government; but his recent comments suggest that “public service” will be a part of his future plans. Gold prices dipped below $1,300 per ounce as markets continue to speculate on the likelihood of additional interest rate hikes in 2018. We believe this is solid buying opportunity for investors. The reason why gold is going to get a nice boost: ongoing trade tensions between the United States and the rest of the globe. Money Morning Resource Specialist Peter Krauth provides his insight on where gold prices are heading next and how you can make big gains in the weeks ahead.
    Three Stocks to Watch Today: AAPL, TWTR, SCGLF
    Apple Inc. (Nasdaq: AAPL) is on the verge of becoming the world’s first $1 trillion company. The stock pushed above $192.60 per share in pre-market hours after its first day at the Worldwide Developers Conference. During the event, the company unveiled its new mobile operating system, called iOS 12. The firm also unveiled a suite of tools designed to combat technology addiction. Shares of Twitter Inc. (NYSE: TWTR) jumped nearly 4% on news that the social media company is about to join the S&P 500. The company will join on Thursday morning and will replace agribusiness giant Monsanto Co. (NYSE: MON). The news comes as Monsanto is in the final steps of its merger with German chemical giant Bayer AG (Nasdaq: BAYRY). Shares of Societe Generale SA (ADR) (OTCMKTS: SCGLF) are in focus after the U.S. Justice Department announced the French investment bank will pay $1.3 billion to settle two ongoing legal headaches. The company bribed Libyan officials and manipulated LIBOR, a benchmark interest rate on which most financing is based. Legg Mason Inc. (NYSE: L

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Guidewire Software (GWRE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Guidewire Software Inc (NYSE:GWRE) shares reached a new 52-week high and low during mid-day trading on Wednesday . The company traded as low as $95.26 and last traded at $93.56, with a volume of 7356 shares changing hands. The stock had previously closed at $94.77.

Top 10 High Tech Stocks To Buy For 2019: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA’s review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
     Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
    Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
    Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
    CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
    NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
    Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
    Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
    Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
    Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

    Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

Best China Stocks To Own For 2019

India is the fastest growing major economy again.

Growth accelerated in the quarter ended December to 7.2%, the government said Wednesday. That’s faster than China’s growth over the same period, and a big jump from the 6.5% India recorded the previous quarter.

The latest GDP numbers point to a clear strengthening of India’s recovery from a sharp slump in the first half of 2017, when growth fell from 7% to a three-year low of 5.7% after two disruptive policy changes by Prime Minister Narendra Modi.

The country was stunned in November 2016 when Modi abruptly banned its two largest currency notes, leading to a sharp slump in many sectors of India’s cash economy. A landmark overhaul of the tax system in July last year also disrupted business, as many companies struggled to adapt to the new regime.

India is expected to further widen the gap over China in 2018, with the International Monetary Fund predicting last month that it will grow by 7.4% this year.

Best China Stocks To Own For 2019: SmartFinancial, Inc.(SMBK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SmartFinancial (NASDAQ:SMBK) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Friday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on SmartFinancial (SMBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best China Stocks To Own For 2019: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
    Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
    Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
    Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
    CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
    NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
    Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
    Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
    Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
    Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

    Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

Best China Stocks To Own For 2019: Xcel Brands, Inc(XELB)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on XCel Brands (XELB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Digital Turbine (NASDAQ: APPS) and XCel Brands (NASDAQ:XELB) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.

Top 10 Heal Care Stocks To Invest In Right Now

Asia-Pacific stocks were largely lower Friday, with markets getting little direction from European and U.S. activity overnight, after what has been a choppy trading week.

The declines came against a backdrop of more political rumblings globally: U.S. sanctions against Russia, reshuffles in the White House and Special Counsel Robert Muellers decision to subpoena the Trump Organization.

Markets are very sensitive to the current politically driven landscape, said Oriano Lizza, a sales trader at CMC Markets.

Top 10 Heal Care Stocks To Invest In Right Now: athenahealth, Inc.(ATHN)

Advisors’ Opinion:

  • [By Lisa Levin]

    athenahealth, Inc. (NASDAQ: ATHN) shares shot up 16 percent to $145.72 after Elliott Management confirmed a $160 per share cash offer for athenahealth.

  • [By Lisa Levin]

    athenahealth, Inc. (NASDAQ: ATHN) shares shot up 24 percent to $156.17 after Elliott Management confirmed a $160 per share cash offer for athenahealth.

  • [By Motley Fool Staff]

    The potential to provide healthcare providers with better solutions for scheduling, billing, and tracking patients’ health has activist investors circling athenahealth(NASDAQ:ATHN). The company’s CEO, Jonathan Bush, might not be interested in selling the company he’s run since 1997, though, because Bush’s vision for athenahealth may conflict too much with activists’ focus on operating profit.

Top 10 Heal Care Stocks To Invest In Right Now: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
    Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
    Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
    Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
    CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
    NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
    Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
    Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
    Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
    Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

    Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

Top 10 Heal Care Stocks To Invest In Right Now: DSP Group Inc.(DSPG)

Advisors’ Opinion:

  • [By Max Byerly]

    AU Optronics (NYSE: AUO) and DSP Group (NASDAQ:DSPG) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, risk and valuation.

  • [By Shane Hupp]

    Needham & Company LLC restated their buy rating on shares of DSP Group (NASDAQ:DSPG) in a report issued on Friday morning. The firm currently has a $15.00 price objective on the semiconductor company’s stock.

Top 10 Heal Care Stocks To Invest In Right Now: MarketAxess Holdings, Inc.(MKTX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Polen Capital Management LLC grew its holdings in MarketAxess Holdings, Inc. (NASDAQ:MKTX) by 42.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,852 shares of the financial services provider’s stock after purchasing an additional 552 shares during the period. Polen Capital Management LLC’s holdings in MarketAxess were worth $403,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    MarketAxess (NASDAQ: MKTX) and Gleacher & Co. Ltd. (OTCMKTS:GLCH) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Top 10 Heal Care Stocks To Invest In Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Max Byerly]

    Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Invest In Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Swiss National Bank grew its position in shares of TherapeuticsMD Inc (NASDAQ:TXMD) by 4.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 301,400 shares of the company’s stock after purchasing an additional 11,600 shares during the quarter. Swiss National Bank owned approximately 0.14% of TherapeuticsMD worth $1,468,000 as of its most recent SEC filing.

  • [By Max Byerly]

    TherapeuticsMD (NASDAQ:TXMD) was given a $12.00 price target by analysts at Oppenheimer Holdings Inc.. The firm currently has a buy rating on the stock.

  • [By Ethan Ryder]

    Shares of TherapeuticsMD Inc (NASDAQ:TXMD) have been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $14.63.

  • [By Brian Feroldi]

    After receiving some analyst love, shares of TherapeuticsMD (NASDAQ:TXMD),a commercial-stage biopharma focused on women’s health, rose 13% as of 3:35 p.m. EDT Tuesday.

  • [By Ethan Ryder]

    TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

Top 10 Heal Care Stocks To Invest In Right Now: Laboratory Corporation of America Holdings(LH)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the headlines that may have impacted Accern’s analysis:

    Get LabCorp alerts:

    $2.92 Earnings Per Share Expected for LabCorp (LH) This Quarter (americanbankingnews.com) Global Contract Research Organization Market 2018 Pioneers by 2023: Parexel, LabCorp (Covance), PRA, PPD … (theexpertconsulting.com) OmniSeq and LabCorp Launch OmniSeq Advance? Assay (nasdaq.com) LabCorp’s latest collaboration aims to accelerate personalized, genomic medicine (bizjournals.com) Can Laboratory Corporation of America Holdings (NYSE:LH) Continue To Outperform Its Industry? (finance.yahoo.com)

    LH has been the topic of several analyst reports. Barclays lifted their target price on shares of LabCorp from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, February 26th. They noted that the move was a valuation call. Zacks Investment Research raised shares of LabCorp from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Friday, February 9th. Jefferies Group reaffirmed a “hold” rating and issued a $176.00 target price on shares of LabCorp in a research note on Tuesday, March 6th. ValuEngine raised shares of LabCorp from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, Morgan Stanley lifted their target price on shares of LabCorp from $182.00 to $192.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 28th. Five research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. LabCorp has an average rating of “Buy” and an average target price of $191.06.

  • [By Max Byerly]

    MUFG Americas Holdings Corp trimmed its stake in LabCorp (NYSE:LH) by 55.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,683 shares of the medical research company’s stock after selling 13,073 shares during the quarter. MUFG Americas Holdings Corp’s holdings in LabCorp were worth $1,728,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    Laboratory Corp. of America (NYSE: LH) and OpGen (NASDAQ:OPGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

  • [By Joseph Griffin]

    Envestnet Asset Management Inc. reduced its position in shares of LabCorp (NYSE:LH) by 45.1% during the first quarter, HoldingsChannel.com reports. The fund owned 19,179 shares of the medical research company’s stock after selling 15,727 shares during the quarter. Envestnet Asset Management Inc.’s holdings in LabCorp were worth $3,116,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

    Get Laboratory Corp. of America alerts:

    Stock Traders Buy Large Volume of Laboratory Corp. of America Put Options (LH) (americanbankingnews.com) Credit Suisse Group Lowers Laboratory Corp. of America (LH) to Hold (americanbankingnews.com) Laboratory Corp. of America (LH) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com) Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings? (finance.yahoo.com) As Laboratory Corp Of America Holdings (LH) Shares Rose, Shareholder Veritas Investment Management Llp … (djzplanet.com)

    LH has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $204.00 price target (up from $180.00) on shares of Laboratory Corp. of America in a research note on Wednesday, February 7th. Morgan Stanley upped their target price on Laboratory Corp. of America from $182.00 to $192.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. Zacks Investment Research downgraded Laboratory Corp. of America from a “hold” rating to a “sell” rating in a research report on Wednesday, January 3rd. Mizuho set a $178.00 target price on Laboratory Corp. of America and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Finally, Robert W. Baird set a $183.00 target price on Laboratory Corp. of America and gave the stock a “hold” rating in a research report on Thursday, February 8th. Seven investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $189.19.

Top 10 Heal Care Stocks To Invest In Right Now: Calumet Specialty Products Partners L.P.(CLMT)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) is attempting to shift gears as it refocuses around higher-margin refined chemicals products. The plan sounds good on paper, and the independent refiner appears to be making progress. However, after a doubling of the price over the past year, most investors need to think carefully before jumping on this bandwagon. Here’s why.

  • [By Tyler Crowe]

    After years of languishing in penny stock territory, shares of Calumet Specialty Products Partners (NASDAQ:CLMT) have had a nice run over the past year as its income statement is starting to show the results of management’s turnaround program. This past quarter, the company’s headline numbers didn’t quite show the progress we have seen in prior ones, but there are still reasons to believe that things are picking up at this specialty chemical producer and oil refiner.

  • [By Stephan Byrd]

    Calumet Specialty Products Partners (NASDAQ:CLMT) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Saturday.

  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
  • [By Lisa Levin]

    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is estimated to report quarterly loss at $0.36 per share on revenue of $757.65 million.

    Pointer Telocation Ltd. (NASDAQ: PNTR) is projected to report quarterly earnings at $0.22 per share on revenue of $20.22 million.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 10 Heal Care Stocks To Invest In Right Now: Legacy Reserves LP(LGCY)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, the energy shares surged 2.8 percent. Meanwhile, top gainers in the sector included Dorian LPG Ltd. (NYSE: LPG), up 11 percent, and Legacy Reserves LP (NASDAQ: LGCY) up 17 percent.

  • [By Money Morning News Team]

    And after taking a look at our 10 top penny stocks to watch, we’ll show you a small-cap stock that just signed a deal with Facebook Inc. (Nasdaq:FB)…

    Penny Stock Current Share Price Law Week’s Gain
    Blink Charging Co. (Nasdaq: BLNK) $6.00 288.51%
    Enterprise GP Holdings LP (NYSE: EPE) $2.94 44.00%
    Opko Health Inc. (Nasdaq: OPK) $4.79 43.49%
    MYnd Analytics Inc. (Nasdaq: MYND) $3.15 38.84%
    Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) $0.52 37.80%
    Mid-Con Energy Partners LP (Nasdaq: MCEP) $2.08 36.81%
    VAALCO Energy (NYSE: EGY) $1.49 36.04%
    Cel-Sci Corp. (NYSE: CVM) $3.16 35.04%
    WideOpenWest Inc. (NYSE: WOW) $8.41 34.52%
    Legacy Reserves LP (Nasdaq: LGCY) $8.43 33.61%

    While these gains are certainly exciting, it’s important to recognize that investing in penny stocks is also a risky investment strategy.

  • [By Ethan Ryder]

    Shares of Legacy Reserves LP (NASDAQ:LGCY) traded up 2.6% during mid-day trading on Thursday . The company traded as high as $7.45 and last traded at $7.75. 42,406 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 501,679 shares. The stock had previously closed at $7.55.

  • [By Matthew DiLallo]

    Legacy Reserves (NASDAQ:LGCY) continued its torrid run on Wednesday, rising another 20% by 12:45 p.m. EDT after one of the company’s largest investors revealed the purchase of additional units. That brings the oil and gas producer’s year-to-date rally up over 250% as fears concerning its future have quickly faded alongside higher oil prices.

  • [By Shane Hupp]

    Legacy Reserves LP (NASDAQ:LGCY) hit a new 52-week high and low on Tuesday . The stock traded as low as $8.74 and last traded at $8.63, with a volume of 42189 shares. The stock had previously closed at $8.36.

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top 10 Heal Care Stocks To Invest In Right Now: EZCORP, Inc.(EZPW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SG Americas Securities LLC increased its position in EZCorp. (NASDAQ:EZPW) by 12.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 258,988 shares of the credit services provider’s stock after purchasing an additional 27,770 shares during the quarter. SG Americas Securities LLC owned approximately 0.48% of EZCorp. worth $3,419,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    EZCORP (NASDAQ: EZPW) and Zagg (NASDAQ:ZAGG) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

  • [By Joseph Griffin]

    News headlines about EZCORP (NASDAQ:EZPW) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. EZCORP earned a news impact score of 0.05 on Accern’s scale. Accern also gave press coverage about the credit services provider an impact score of 45.6717362487943 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Max Byerly]

    JPMorgan Chase & Co. decreased its position in shares of EZCORP Inc (NASDAQ:EZPW) by 25.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,230,426 shares of the credit services provider’s stock after selling 417,887 shares during the period. JPMorgan Chase & Co. owned about 2.26% of EZCORP worth $16,241,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Clean Energy Stocks To Watch For 2018

President Donald Trump retreated from imposing tariffs on billions of dollars worth of Chinese goods because of White House discord over trade strategy and concern about harming negotiations with North Korea, according to people briefed on the administration’s deliberations.

Trump also succumbed to pressure from farm-state Republicans, who heavily lobbied the White House to resolve its trade differences with China, which had especially targeted U.S. agricultural products with planned retaliatory tariffs.

Treasury Secretary Steven Mnuchin said Sunday that the administration’s plan to impose tariffs had been suspended, and Trump said on Twitter on Monday that the Chinese had agreed to purchase unspecified amounts of American farm products. Some of his loyalists led by former chief strategist Steven Bannon criticized the deal as a capitulation.

The agreement at least delays a trade war between the world’s two largest economies, a prospect that has rattled financial markets for months. But many U.S. concerns about China’s economic practices remain unresolved: its acquisition of American technologies; the country’s plans to subsidize the growth of advanced domestic industries such as artificial intelligence and clean energy; and U.S. companies’ access to China’s markets.

Top 10 Clean Energy Stocks To Watch For 2018: Carbonite, Inc.(CARB)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Carbonite Inc. (NASDAQ: CARB) was reiterated as Outperform and the price target was raised to $35 from $30 at Oppenheimer.

    Carrizo Oil & Gas Inc. (NASDAQ: CRZO) was maintained as Buy but the price target was cut to $44 from $45 at Stifel.

  • [By Logan Wallace]

    Carbonite Inc (NASDAQ:CARB) shares reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $37.23 and last traded at $37.20, with a volume of 8859 shares changing hands. The stock had previously closed at $36.32.

  • [By Logan Wallace]

    Mackay Shields LLC bought a new position in shares of Carbonite Inc (NASDAQ:CARB) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 49,600 shares of the technology company’s stock, valued at approximately $1,428,000.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Carbonite (CARB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Watch For 2018: Limelight Networks Inc.(LLNW)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Limelight Networks, Inc. (NASDAQ: LLNW) got a boost, shooting up 26 percent to $5.17 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Limelight Networks (LLNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    (Nasdaq: CNET)

    $2.95 34.76%
    Seadrill Ltd. (NYSE: SDRL) $0.28 33.81%
    Intelsat Corp. (NYSE: I) $9.11 31.50%
    Navios Maritime Midstream Partners LP (NYE: NAP) $4.42 29.18%
    Limelight Networks Inc. (Nasdaq: LLNW) $4.89 28.61%
    Enphase Energy Inc. (Nasdaq: ENPH) $5.05 24.62%

    As you can see in the table above, penny stocks have the potential to provide tremendous returns for enterprising investors. However, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance.
    Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter.
    New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday.
    Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading.
    Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday.
    Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results.
    Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday.
    Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading.
    Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading.
    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

Top 10 Clean Energy Stocks To Watch For 2018: Allison Transmission Holdings, Inc.(ALSN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ARP Americas LP lowered its stake in shares of Allison Transmission (NYSE:ALSN) by 8.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,497 shares of the auto parts company’s stock after selling 1,400 shares during the quarter. ARP Americas LP’s holdings in Allison Transmission were worth $566,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Allison Transmission (NYSE:ALSN) announced a quarterly dividend on Thursday, May 10th, Zacks reports. Stockholders of record on Monday, May 21st will be given a dividend of 0.15 per share by the auto parts company on Thursday, May 31st. This represents a $0.60 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Friday, May 18th.

  • [By Stephan Byrd]

    Allison Transmission (NYSE:ALSN) – Investment analysts at Oppenheimer increased their FY2018 earnings per share (EPS) estimates for Allison Transmission in a research note issued on Monday, April 30th. Oppenheimer analyst I. Zaffino now expects that the auto parts company will post earnings of $3.79 per share for the year, up from their previous forecast of $3.32. Oppenheimer also issued estimates for Allison Transmission’s FY2019 earnings at $4.16 EPS.

Top 10 Clean Energy Stocks To Watch For 2018: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Paul Ausick]

    Prothena Corp. plc (NASDAQ: PRTA) traded down 70% Monday to post a new 52-week low of $11.05 after closing Friday at $36.84. The stock’s 52-week high is $70.00. Volume was more than 20 times the daily average of around 580,000 shares. The company is stopping development on an amyloidosis treatment following a failed late-stage trial.

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By Jon C. Ogg]

    Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment fails in a drug study. Now it looks as if Prothena Corporation plc (NASDAQ: PRTA) is on the verge of implosion based upon how its stock price reacted.

  • [By Cory Renauer]

    April’s been a month of biotech bloodbaths. In a 15-day span, Incyte Corporation (NASDAQ:INCY), Prothena Corporation PLC (NASDAQ:PRTA), and Celldex Therapeutics Inc. (NASDAQ:CLDX)have all reported clinical trial failures that have hammered theirstock prices.

Top 10 Clean Energy Stocks To Watch For 2018: MSA Safety Incorporporated(MSA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of Mine Safety Appliances (NYSE:MSA) have been given an average rating of “Hold” by the six research firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $97.33.

  • [By Shane Hupp]

    Mine Safety Appliances (NYSE: MSA) is one of 26 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Mine Safety Appliances to similar companies based on the strength of its risk, earnings, institutional ownership, valuation, dividends, analyst recommendations and profitability.

Top 10 Clean Energy Stocks To Watch For 2018: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

Top 10 Clean Energy Stocks To Watch For 2018: Northwest Natural Gas Company(NWN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Northwest Natural Gas (NWN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Northwest Natural Gas (NWN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    NW Natural (NYSE:NWN) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday.

Top 10 Clean Energy Stocks To Watch For 2018: OGE Energy Corporation(OGE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on OGE Energy (OGE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    SG Americas Securities LLC increased its position in OGE Energy Corp. (NYSE:OGE) by 24.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 54,097 shares of the utilities provider’s stock after buying an additional 10,617 shares during the quarter. SG Americas Securities LLC’s holdings in OGE Energy were worth $1,773,000 at the end of the most recent reporting period.

Top 10 Clean Energy Stocks To Watch For 2018: Smith Micro Software Inc.(SMSI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the news stories that may have impacted Accern’s scoring:

    Get Smith Micro Software alerts:

    Short Interest in Smith Micro Software (SMSI) Increases By 51.9% (americanbankingnews.com) Smith Micro Software’s (SMSI) CEO Bill Smith on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) Smith Micro Software (SMSI) Reports Q1 Loss of $0.10 (streetinsider.com) Smith Micro Reports First Quarter 2018 Financial Results (finance.yahoo.com) Smith Micro announces above market USD 7.0m private placement offering (financial-news.co.uk)

    Separately, ValuEngine upgraded shares of Smith Micro Software from a “sell” rating to a “hold” rating in a report on Friday, February 2nd.

Top 10 Clean Energy Stocks To Watch For 2018: Dean Foods Company(DF)

Advisors’ Opinion:

  • [By ]

    Analysts said the are “now more cautious on names with unfavorable grocer/retailer exposure where we still see downside to estimates (Dean Foods Co. (DF) , downgraded to sell earlier this week) and those losing share within categories/lack of catalysts (PepsiCo Inc. (PEP) ).”

  • [By Lisa Levin]

    Analysts at Deutsche Bank downgraded Dean Foods Company (NYSE: DF) from Hold to Sell.

    Dean Foods shares fell 0.19 percent to $10.45 in pre-market trading.

  • [By Lisa Levin]

    Tuesday morning, the consumer staples shares surged 0.57 percent. Meanwhile, top gainers in the sector included Dean Foods Company (NYSE: DF), up 3 percent, and Viña Concha y Toro S.A. (NYSE: VCO) up 3 percent.

  • [By Shane Hupp]

    Deutsche Bank cut shares of Dean Foods (NYSE:DF) from a hold rating to a sell rating in a research report sent to investors on Monday morning, MarketBeat Ratings reports. They currently have $9.00 target price on the stock.

  • [By Lisa Levin] Gainers
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 50.7 percent to $4.34 after the company announced a special $1.00 per share cash dividend.
    Impinj, Inc. (NASDAQ: PI) surged 28.4 percent to $17.44 after reporting Q1 results.
    Cardlytics, Inc. (NASDAQ: CDLX) gained 22 percent to $17.945.
    Care.com, Inc. (NYSE: CRCM) shares rose 19.3 percent to $18.92 following Q1 earnings.
    Sharing Economy International Inc. (NASDAQ: SEII) jumped 19.1 percent to $4.3934 after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Blink Charging Co. (NASDAQ: BLNK) rose 18.6 percent to $4.79 after jumping 171.14 percent on Monday.
    IntriCon Corporation (NASDAQ: IIN) climbed 17.4 percent to $29.30 after reporting Q1 results.
    Nevsun Resources Ltd. (NYSE: NSU) rose 16.2 percent to $3.45 after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Tactile Systems Technology, Inc. (NASDAQ: TCMD) gained 15.4 percent to $42.61 following Q1 results.
    eGain Corporation (NASDAQ: EGAN) gained 15.3 percent to $10.55 following Q3 earnings.
    Dean Foods Company (NYSE: DF) rose 13.8 percent to $9.48 after reporting upbeat Q1 earnings.
    Sterling Construction Company, Inc. (NASDAQ: STRL) shares surged 13.1 percent to $13.42 after reporting Q1 results.
    USA Technologies, Inc. (NASDAQ: USAT) climbed 11.9 percent to $10.85 following better-than-expected Q3 earnings.
    scPharmaceuticals Inc. (NASDAQ: SCPH) gained 11.2 percent to $14.45 following Q1 results.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 10.2 percent to $24.08 following Q1 results.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 7.9 percent to $19.60 as the company posted upbeat Q1 results and raised its outlook.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 7.7 percent to $11.90 following upbeat Q1 results.
    Pareteum Corporation (NASDAQ: TEUM) rose 6.8 perc
  • [By Lisa Levin] Gainers
    Integrated Media Technology Limited (NASDAQ: IMTE) rose 30.8 percent to $22.00 in pre-market trading after declining 18.63 percent on Monday.
    Nevsun Resources Ltd. (NYSE: NSU) rose 14.5 percent to $3.40 in pre-market trading after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Sharing Economy International Inc. (NASDAQ: SEII) rose 15.2 percent to $4.25 in pre-market trading after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Veeco Instruments Inc. (NASDAQ: VECO) shares rose 14.1 percent to $19.50 in pre-market trading after reporting stronger-than-expected earnings for its first quarter.
    Impinj, Inc. (NASDAQ: PI) rose 13.4 percent to $15.40 in pre-market trading after reporting Q1 results.
    SandRidge Energy, Inc. (NYSE: SD) shares rose 13.2 percent to $16.45 in pre-market trading following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 12.6 percent to $4.55 in pre-market trading after jumping 171.14 percent on Monday.
    Crocs, Inc. (NASDAQ: CROX) shares rose 10 percent to $16.66 in pre-market trading after the company reported better-than-expected earnings for its first quarter and issued strong sales forecast for the second quarter.
    Pareteum Corporation (NASDAQ: TEUM) rose 9.7 percent to $3.05 in pre-market trading after announcing Q1 results.
    Dean Foods Company (NYSE: DF) rose 8 percent to $9.00 in pre-market trading after reporting upbeat Q1 earnings.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 7.3 percent to $23.45 in pre-market trading following Q1 results.
    IAMGOLD Corporation (NYSE: IAG) rose 7.1 percent to $6.09 in pre-market trading after reporting upbeat Q1 earnings.
    TC PipeLines, LP (NYSE: TCP) rose 6.4 percent to $27 in pre-market trading after gaining 2.08 percent on Monday.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 6.3 percent to $11.75 in pre-market trading fol

Top Blue Chip Stocks To Own For 2018

I really have an active dislike for the term “blue-chip stock.”

Plain and simple: the term is outdated. A lot of large-cap familiar names are still called “blue-chip stock” when they are nothing of the kind. If you can’t rid the term “blue-chip stock” from your lexicon, then it should at least apply to a whole new stream of companies.

“Blue-chip stock” used to refer to companies that were constantly growing earnings in the high single-digits or more in terms of percentage, had a fortress balance sheet and were constantly innovating. The seven stocks I’m about to talk about have either none of these traits or, at best, have a really solid balance sheet.

Compare Brokers

Blue-Chip Stocks That Aren’t Really Blue Chips: IBM

Let’s start with International Business Machines Corp. (NYSE:IBM), a former blue-chip stock, which the world has left so far behind that even Warren Buffett sold out of his position.

Top Blue Chip Stocks To Own For 2018: Tennessee Valley Authority(TVE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Tamarack-Valley-Energy (CVE:TVE) had its price objective raised by equities research analysts at BMO Capital Markets from C$3.75 to C$4.50 in a research note issued on Friday. BMO Capital Markets’ target price points to a potential downside of 82.02% from the stock’s current price.

Top Blue Chip Stocks To Own For 2018: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

Top Blue Chip Stocks To Own For 2018: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By ]

    In his second “Executive Decision” segment, Cramer checked in with Nick Akins, chairman, president and CEO of American Electric Power (AEP) , the utility that just posted a two-cents-a-share earnings miss, but reiterated their full-year guidance. Shares of American Electric Power are down 5.1% for the year but yield 3.6%.

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter
  • [By Reuben Gregg Brewer]

    On the surface, American Electric Power Company, Inc. (NYSE:AEP) is a pretty simple business to understand — it generates and distributes electricity. But when you dig under the surface a little, you start to see that its business has changed materially in recent years. More important, AEP is now positioned to take advantage of industry shifts taking place in the power sector. Here’s how AEP makes most of its money and why its prospects for slow and steady growth are so strong.

Top Blue Chip Stocks To Own For 2018: BioMarin Pharmaceutical Inc.(BMRN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the headlines that may have impacted Accern Sentiment’s scoring:

    Get BioMarin Pharmaceutical alerts:

    BioMarin Pharmaceutical (BMRN) Director Sells $318,750.00 in Stock (americanbankingnews.com) BioMarin Pharmaceutical (BMRN) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com) BioMarin Pharmaceutical’s (BMRN) “Outperform” Rating Reiterated at BMO Capital Markets (americanbankingnews.com) Three healthcare stocks driving the gene therapy momentum (ca.finance.yahoo.com) 4 Red-Hot Biotech Stocks to Buy Before Earnings (247wallst.com)

    Shares of BioMarin Pharmaceutical stock traded down $1.32 on Friday, hitting $82.30. 2,278,721 shares of the company’s stock traded hands, compared to its average volume of 1,207,934. BioMarin Pharmaceutical has a one year low of $75.81 and a one year high of $100.51. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.70 and a quick ratio of 2.12. The firm has a market cap of $14,490.73, a price-to-earnings ratio of -122.84 and a beta of 1.69.

  • [By ]

    This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV)  , Amgen (AMGN)  , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN)  and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days,” according to Real Money Pro columnist Bret Jensen.

  • [By ]

    BioMarin Pharmaceutical (Nasdaq: BMRN) is a leader in the orphan drug category (drugs used to treat rare diseases), which gives it extended protection and a longer sales trajectory versus other pharmaceuticals. The company is expected to bring its PKU treatment Pegvaliase to market this year to add significantly to sales and blockbusters Vosoritide and Valrox could come to market within the next two years.

  • [By Chris Lange]

    BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is expected to report its most recent quarterly results on February 22. The consensus estimates from Thomson Reuters are calling for a net loss of $0.24 per share on $357.49 million in revenue. The same period of last year had a net loss of $0.53 per share and $300.09 million in revenue. Shares of BioMarin were last seen at $84.98, with a consensus price target of $110.32 and a 52-week range of $78.50 to $100.51.

  • [By Chris Lange]

    BioMarin Pharmaceutical Inc.’s (NASDAQ: BMRN) first-quarter results are due late on Wednesday. The consensus forecast calls for a net loss of $0.18 per share and revenue of $348.57 million. The shares ended last week at $82.30. The consensus analyst target is $114.30. The 52-week trading range is $75.81 to $100.51.

Hot Heal Care Stocks To Own Right Now

Hormel Foods Corp (HRL) has been named to the Dividend Channel ”S.A.F.E. 25” list, signifying a stock with above-average ”DividendRank” statistics including a strong 2.0% yield, as well as a superb track record of at least two decades of dividend growth, according to the most recent ”DividendRank” report.

According to the ETF Finder at ETF Channel, Hormel Foods is a member of the iShares S&P 1500 Index ETF (ITOT), and is also an underlying holding representing 0.55% of the SPDR S&P Dividend ETF (SDY), which holds $82,452,699 worth of HRL shares.

Hormel Foods made the “Dividend Channel S.A.F.E. 25” list because of these qualities: S. Solid return — hefty yield and strong DividendRank characteristics; A. Accelerating amount — consistent dividend increases over time; F. Flawless history — never a missed or lowered dividend; E. Enduring — at least two decades of dividend payments.

START SLIDESHOW:
Top 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades »

Hot Heal Care Stocks To Own Right Now: ONEOK Inc.(OKE)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    For an example of just how important this is, take a look at the graph below. Midstream companies ONEOK Inc. (NYSE:OKE), Magellan Midstream Partners LP(NYSE:MMP), and Enterprise Products Partners L.P. (NYSE:EPD) have each increased their disbursements for more than a decade. However, there is a difference in the growth rates over time. Enterprise’s 10-year annualized distribution increase was 5.7%, Magellan’s was 10.9%, and ONEOK’s dividend rose at an annualized 16.1% clip. Just a few percentage points here makes a huge difference in the growth of the disbursement over time, as the chart below clearly shows.

  • [By Max Byerly]

    Bronfman E.L. Rothschild L.P. increased its holdings in ONEOK (NYSE:OKE) by 86.1% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 14,456 shares of the utilities provider’s stock after buying an additional 6,690 shares during the quarter. Bronfman E.L. Rothschild L.P.’s holdings in ONEOK were worth $823,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    ONEOK (NYSE:OKE) – Analysts at US Capital Advisors raised their FY2018 EPS estimates for ONEOK in a research report issued to clients and investors on Monday, May 14th. US Capital Advisors analyst B. Followill now anticipates that the utilities provider will post earnings of $2.74 per share for the year, up from their previous forecast of $2.56. US Capital Advisors also issued estimates for ONEOK’s Q4 2018 earnings at $0.74 EPS and FY2019 earnings at $2.95 EPS.

  • [By Reuben Gregg Brewer]

    Kinder Morgan, Inc. (NYSE:KMI) is one of the largest midstream companies in North America, and it has major dividend plans between 2018 and 2020. By the end of that period, it expects to increase its dividend from $0.50 per share per year (in 2017) to $1.25. That’s huge dividend growth in a short period of time. But don’t get too enamored by that news; the dividend will still be lower than it was before the midstream oil and gas company’s 75% dividend cut in 2016. If you’re looking for dividend income in the midstream space, take a look at longtime dividend payers ONEOK, Inc. (NYSE:OKE) and Magellan Midstream Partners, L.P. (NYSE:MMP) instead.

  • [By Max Byerly]

    Prudential Financial Inc. boosted its stake in ONEOK (NYSE:OKE) by 1.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 535,375 shares of the utilities provider’s stock after acquiring an additional 5,560 shares during the period. Prudential Financial Inc.’s holdings in ONEOK were worth $30,474,000 at the end of the most recent reporting period.

Hot Heal Care Stocks To Own Right Now: Profire Energy, Inc.(PFIE)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Acacia Communications, Inc. (NASDAQ: ACIA) shares rose 18.3 percent to $37.25 in pre-market trading after gaining 1.74 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 12.1 percent to $2.69 in pre-market trading after surging 4.80 percent on Friday.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 10.9 percent to $109.75 in pre-market trading after Bloomberg reported that the China’s Commerce Ministry has restarted its review of QUALCOMM Incorporated’s (NASDAQ: QCOM) proposed takeover of NXP Semiconductors.
    Renewable Energy Group, Inc. (NASDAQ: REGI) rose 10.6 percent to $15.20 in pre-market trading. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    NeoPhotonics Corporation (NYSE: NPTN) rose 10 percent to $6.40 in pre-market trading.
    Vaxart, Inc. (NASDAQ: VXRT) shares rose 8 percent to $5.54 in pre-market trading after gaining 2.19 percent on Friday.
    Profire Energy, Inc. (NASDAQ: PFIE) rose 7.3 percent to $4.58 in pre-market trading after gaining 6.22 percent on Friday.
    Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 7 percent to $22.49 in pre-market trading after falling 1.96 percent on Friday.
    Oclaro, Inc. (NASDAQ: OCLR) shares rose 6.9 percent to $9.16 in pre-market trading.
    TransEnterix, Inc. (NYSE: TRXC) rose 5.7 percent to $2.24 in pre-market trading after gaining 3.92 percent on Friday.
    CVR Refining, LP (NYSE: CVRR) rose 5.4 percent to $19.70 in pre-market trading.
    Federal Agricultural Mortgage Corporation (NYSE: AGM) rose 5.2 percent to $92.95 in pre-market trading.
    International Game Technology PLC (NYSE: IGT) rose 5.2 percent to $29.94 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 5.1 percent to $66.30 in the pre-market trading session.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5 percent to $10.70 in pre-market trading after climbing 15.66 percent on Friday.
    Finisar

Hot Heal Care Stocks To Own Right Now: Genuine Parts Company(GPC)

Advisors’ Opinion:

  • [By ]

    2. Price To Sales
    Another useful metric is the price-to-sales ratio (P/S). P/S measures a company’s market cap versus its annual revenue number. The idea is that the lower the number, the greater the implied value. For example, Snap, Inc. (Nasdaq: SNAP) trades at 26.9 times sales, an incredibly expensive number. However, aftermarket auto parts giant Genuine Parts (NYSE: GPC) trades at just 0.88 times sales — 88 cents to every dollar of sales the company brings in. Often, the lower the number, the more inefficiently the market has mispriced the stock.

  • [By ]

    Genuine Parts Co. (NYSE: GPC)
    Ok, now I know I’ve definitely locked in the broken record award. GPC is better known to consumers as NAPA auto parts. And aftermarket auto parts is probably one of the most lucrative businesses in the United States for too many reasons to cover now.

Hot Heal Care Stocks To Own Right Now: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

Hot Heal Care Stocks To Own Right Now: CrossAmerica Partners LP(CAPL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    CrossAmerica Partners (NYSE:CAPL) – Research analysts at Jefferies Group reduced their FY2018 earnings estimates for CrossAmerica Partners in a research note issued to investors on Wednesday, May 9th. Jefferies Group analyst C. Mandeville now forecasts that the oil and gas company will earn $0.24 per share for the year, down from their previous forecast of $0.32. Jefferies Group currently has a “Buy” rating and a $28.00 target price on the stock. Jefferies Group also issued estimates for CrossAmerica Partners’ Q1 2019 earnings at $0.07 EPS, Q2 2019 earnings at $0.13 EPS, Q4 2019 earnings at $0.14 EPS and FY2020 earnings at $0.42 EPS.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CrossAmerica Partners (CAPL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks To Watch For 2019

There are a number of great companies in the market today. By using the ModernGraham valuation model, I have selected the 10 lowest PEmg (price to normalized earnings) companies. Each company has been determined to be undervalued and suitable for the Defensive Investor according to the ModernGraham approach.

Defensive Investors are defined as investors who are not able or willing to do substantial research into individual investments, and therefore need to select only the companies that present the least amount of risk. Enterprising Investors, on the other hand, are able to do substantial research and can select companies that present a moderate (though still low) amount of risk.

Bed Bath & Beyond Inc. (NASDAQ:BBBY)

Bed Bath & Beyond qualifies for both the Defensive Investor and the Enterprising Investor. The Defensive Investor is only initially concerned with the poor dividend history. The Enterprising Investor is only concerned with the lack of dividends. As a result, all value investors should feel comfortable proceeding with the analysis.

Hot Undervalued Stocks To Watch For 2019: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By ]

    Genesis Energy LP (NYSE: GEL)
    Billing itself as a “growth-oriented master limited partnership,” GEL concentrates its efforts on providing services around and within refineries primarily located on the Gulf Coast. Management is committed to logical double-digit growth as well as strengthening its distribution coverage. At $20.80 per unit, GEL yields 11.8% and trades at a nearly 40% discount to its 52-week high.

  • [By Lisa Levin]

    Breaking news

    Lennar Corporation (NYSE: LEN) reported better-than-expected profit for its first quarter on Tuesday.
    General Mills, Inc. (NYSE: GIS) reported upbeat earnings for its fiscal third quarter, while sales missed estimates.
    Genesis Energy, L.P. (NYSE: GEL) disclosed that it has priced its public offering of 4 million common units for gross proceeds of $124 million.
    South State Corporation (NASDAQ: SSB) reported that it has increased its buyback plan from 250,000 shares to 1 million shares.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P

Hot Undervalued Stocks To Watch For 2019: ADTRAN Inc.(ADTN)

Advisors’ Opinion:

  • [By Monica Gerson]

    ADTRAN, Inc. (NASDAQ: ADTN) is projected to post its quarterly earnings at $0.08 per share on revenue of $141.07 million.

    Layne Christensen Company (NASDAQ: LAYN) is estimated to post a quarterly loss at $0.35 per share on revenue of $156.10 million.

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

Hot Undervalued Stocks To Watch For 2019: Newell Rubbermaid Inc.(NWL)

Advisors’ Opinion:

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday’s trending topics including Goldman Sachs (GS) , JPMorgan Chase (JPM) , Newell Brands (NWL) and Domino’s Pizza (DPZ) .

  • [By Paul Ausick]

    Newell Brands Inc. (NYSE: NWL) dropped about 1.5% Monday to post a new 52-week low of $42.54 after closing Friday at $43.20. The 52-week high is $55.08. Volume of around 3.5 million shares traded was about 10% above the daily average. The company had no specific news.

  • [By ]

    Not every battle is worth fighting, Cramer told viewers. That’s especially true if you own shares of Newell Brands (NWL) , which is embroiled in a bitter proxy fight between activists Starboard Capital and Carl Icahn.

  • [By ]

    When the facts change, you need to change your mind, Cramer reminded viewers. That’s why Cramer said he’s changed his mind on Newell Brands (NWL) after the company came to an agreement with activist investors Starboard Capital, ending a proxy fight Cramer featured on “Mad Money” just last week.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Newell Brands Inc. (NYSE: NWL) which traded downover 3% at $47.10. The stocks 52-week range is $43.43 to $55.08. Volume was nearly 17 million versus the daily average of 3.3 million shares.

Hot Undervalued Stocks To Watch For 2019: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

Hot Undervalued Stocks To Watch For 2019: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

  • [By Jon C. Ogg]

    The biotechs and emerging pharma havebeen under pressure from politicians attacking drug prices. That doesn’t mean that there are not some big winners out there. Sometimes the biggest winners are companies most investors have never heard of. Even if you have been a biotech and emerging pharma investor for years, chances are high that you would have never heard of a small outfit called Apricus Biosciences Inc. (NASDAQ: APRI).

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.